Clinical Trials Directory

Trials / Terminated

TerminatedNCT01572194

Predictive Value of PIIINP Urinary for the Development of Chronic Renal Failure in Patients With Cystic Fibrosis After Lung Transplantation (MUCO-IRC)

Predictive Value of PIIINP Urinary for the Development of Chronic Renal Failure in Patients With Cystic Fibrosis After Lung Transplantation.

Status
Terminated
Phase
N/A
Study type
Interventional
Enrollment
45 (actual)
Sponsor
Nantes University Hospital · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Chronic renal failure is a serious complication of lung transplantation especially in patients with cystic fibrosis. Their medical history prior to the Lung Transplantation has already exposed to kidney damage. Post-lung transplantation, these patients are subjected to renal toxicity anticalcineurins they receive large doses. The measurement of renal function of patients by formula to estimate GFR in routine use is unreliable and other markers seem indispensable. The purpose of this study is to evaluate two markers, PIIINP (Procollagen III aminoterminal peptide N), whose urinary levels was correlated to the intensity of fibrosis in different types of kidney disease.

Conditions

Interventions

TypeNameDescription
BIOLOGICALUrinary levels of PIIINP as a marker of changes in renal functionThe act under consideration is the determination of PIIINP urinary. The aim of the study is to show the predictive value of PIIINP urinary in assessing renal function in patients with mucoviscidosis receiving a lung transplant.

Timeline

Start date
2012-04-01
Primary completion
2018-04-01
Completion
2018-04-01
First posted
2012-04-06
Last updated
2018-04-23

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT01572194. Inclusion in this directory is not an endorsement.